Vivani Medical VANI Neuromodulation Division — Other Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's neuromodulation division — other nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's neuromodulation division — other nonoperating income expense?
- Vivani Medical (VANI) reported neuromodulation division — other nonoperating income expense of $42K in Q1 2026.
- How has Vivani Medical's neuromodulation division — other nonoperating income expense changed year-over-year?
- Vivani Medical's neuromodulation division — other nonoperating income expense increased by 2.4% year-over-year, from $41K to $42K.
- What does neuromodulation division — other nonoperating income expense mean?
- This metric includes financial gains or losses generated by the Neuromodulation Division that are outside the scope of its primary business operations, such as interest income or miscellaneous non-core items. It helps isolate the impact of peripheral financial activities on the division's overall performance. Investors use this to distinguish between core operational results and incidental financial events.